SpeedWeed
MARCH 11, 2021
The case is about seeking to ensure that patients with serious, life-threatening illness are able to realize the promise of state and federal Right to Try laws and access psilocybin for therapeutic purposes.”. The state said the decision to use these drugs should be made by the patient and their doctor. .
Veriheal
JANUARY 24, 2023
But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. After receiving a petition three years prior, the DEA finally answered with action, making plans to deschedule [18F]FP-CIT , a controlled substance derived from cocaine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
JANUARY 17, 2019
As the result of a lawsuit, DEA Administrative Law Judge Mary Ellen Bittner in 2007 ruled that expanding the pool of federally licensed providers would be “in the public interest.” The agency ultimately rejected her decision. Click here to send a message to your federal lawmaker and urge them to support the measure. .
Cannabis Law Report
JULY 7, 2021
Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. Circuit), a pending petition for review of DEA’s August 2020 Interim Final Rule purportedly implementing the 2018 Farm Bill’s amendments to the CSA.
Veriheal
DECEMBER 1, 2020
Peter Grinspoon, a PCP at Harvard Medical School and board member of the Doctors for Cannabis Regulation advocacy group, says that Delta-8 has vast potential like so many other less known deltas. The DEA is Already Interfering. Way to go, DEA, on jumping the gun showing your true colors.
Veriheal
AUGUST 31, 2020
Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Essay: “Can Cannabis Improve Patient Experience Post-Surgery?” . Program between St. Vaibhav Duggal . School: Texas A&M University .
PrestoDoctor
JULY 16, 2019
In their most recent federal lawsuit, CCA attorneys are representing 5 different plaintiffs, all of whom demonstrate that maintaining cannabis as a schedule 1 drug is unconstitutional and a risk to their health as patients. According to plaintiff José Belén, “the DEA was told to act with ‘great dispatch’ and with ‘all deliberate speed”.
Expert insights. Personalized for you.
52 
Let's personalize your content